|
Apoptotic Regulation and Neuroinflammation in Alzheimers Disease |
1F32AG077861-01 |
|
NIA |
2022 |
|
Isoform-dependent effects of tau phosphorylation in Alzheimers disease |
1F32AG079537-01 |
|
NIA |
2022 |
|
Efficient Brain Delivery of Neuroprotective TrkB Agonist Antibodies in Alzheimer’s Disease Using CD98hc Bispecific Shuttles |
1F32AG079576-01 |
|
NIA |
2022 |
|
Exploring the mechanisms of dysfunctional mitochondrial quality control in cerebrovascular disease and the aging brain |
1F99AG079793-01 |
|
NIA |
2022 |
|
Optical probe and instrumentation development for in vivo near-infrared fluorescence imaging of Alzheimers disease |
1K01AG072046-01A1 |
|
NIA |
2022 |
|
Contribution of somatic mitochondrial DNA mutation to the transition from normal aging to Alzheimers disease |
1K01AG073470-01A1 |
|
NIA |
2022 |
|
Antagonizing tau spreading in Alzheimer’s disease by PI4K2A-mediated lysosomal quality control |
1K01AG075142-01 |
|
NIA |
2022 |
|
Revealing roles of heterosynaptic plasticity in Alzheimers disease |
1K01AG078126-01 |
|
NIA |
2022 |
|
Biomarkers of Inflammation, Neurodegeneration and Age-Associated Cognitive Impairment |
1K01AG078407-01 |
|
NIA |
2022 |
|
Baboon model of chemotherapy-related cognitive impairment and accelerated aging |
1K01AG078411-01 |
|
NIA |
2022 |